Zurich: Takeda has announced that the European Medicines Agency (EMA) has given approval for an additional 2 mL pre-filled ...
Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...
Takeda (TAK) announced that the EMA has approved an additional two mL pre-filled pen option for Takhzyro for subcutaneous administration in ...
Takeda, a global biopharmaceutical company with a manufacturing site in Stanton Springs, unveiled its new Biomedical Waste ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and chief executive officer of Horizon Therapeutics, to the ...
The AVPN Southeast Asia Summit 2025, held at Fairmont Singapore on 24 and 25 February, brought together over 450 investors, ...
A Japanese version of the U.S. Esophageal Hypervigilance and Anxiety Scale questionnaire to investigate the psychological ...
The online arm of CSU said it identified the need for the new programs using job demand and wage data, market trends and ...
We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...
1 (tie), Lauren Coughlin, Georgia Hall, Minjee Lee, Madelene Sagstrom, Maja Stark and Angel Yin, 2. 7, 33 tied with 1. 1 (tie), Jaravee Boonchant, In Gee Chun, Danielle Kang, Ruixin Liu, Ryann O'Toole ...
WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of ...
TOKYO, Jan 30 (Reuters) - Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results